The overall goal of this project is to investigate the molecular basis for and biological effects of ATG4B activation in glioblastoma (GBM), the most common and aggressive primary brain tumor. Our preliminary results, as well as the results of others, demonstrate an important role for ATG4B in autophagy, a conserved catabolic process for regulating cellular energetic balance as well as cellular response to stress. Cancer cells use autophagy: (1) to remove damaged organelles and damaged and non-functioning proteins, and to recycle highly demanded nutrients to further tumor growth; and (2) as a survival mechanism in response to therapy. A key activity of ATG4B is its conversion of LC3 to LC3-I/II for autophagysome integration, which, in turn, is necessary for tumor cell survival, continued growth, and for tumor cell autophagic response to therapies. We show here that ATG4B activity is regulated by MST4, a serine/threonine kinase that induces robust phosphorylation ATG4B at serine 383. This provides the basis for the overarching hypothesis of this proposal: that MST4-induced phosphorylation of ATG4B is required for GBM autophagic response, which, in turn contributes to tumor cell survival, growth and resistance to therapy. We will address this hypothesis in the context of three specific aims: 1) determine how MST4 induces phosphorylation of ATG4B, and in doing so influences GBM autophagy and tumorigenicity; 2) determine the role of phosphorylation of ATG4B in autophagy, GBM tumorigenicity, and association with GBM patient prognosis.; and 3) determine whether suppressing ATG4B and/or MST4 affects GBM response to radiation and temozolomide (TMZ) treatments. The proposed studies are significant in that this project will establish ATG4B as an essential contributor to GBM growth and response to therapy, and that these activities depend on MST4-induced phosphorylation. This knowledge, in turn, will help identify points of therapeutic intervention for improved treatment outcomes for GBM patients.

Public Health Relevance

In malignant glioblastoma (GBM), autophagy-mediated intracellular recycling sustains tumor metabolism, growth and survival favors tumor growth and progression. Autophagy in response to therapeutic treatments such as radiation and chemotherapies also provides a mechanism for GBM cell to survive and acquire resistance to therapies. This application will test a hypothesis that ATG4B, a key enzyme in autophagic process contributes to GBM autophagic response, malignant phenotypes, and response to therapy, by MST4 activation of ATG4B through S383 phosphorylation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS095634-01
Application #
9053937
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Fountain, Jane W
Project Start
2015-09-30
Project End
2020-06-30
Budget Start
2015-09-30
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$337,969
Indirect Cost
$119,219
Name
Northwestern University at Chicago
Department
Neurology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Lv, Deguan; Li, Yanxin; Zhang, Weiwei et al. (2017) TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. Nat Commun 8:1454
Huang, Tianzhi; Kim, Chung Kwon; Alvarez, Angel A et al. (2017) MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell 32:840-855.e8
Lv, Deguan; Jia, Feng; Hou, Yanli et al. (2017) Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding. Cancer Res 77:6190-6201
Hashizume, Rintaro; Zhang, Ali; Mueller, Sabine et al. (2016) Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. Neuro Oncol 18:1519-1528
Eckerdt, Frank; Alvarez, Angel; Bell, Jonathan et al. (2016) A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids. Biotechniques 60:43-6
Bell, Jonathan B; Eckerdt, Frank D; Alley, Kristen et al. (2016) MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma. Mol Cancer Res 14:984-993
Huang, Tianzhi; Alvarez, Angel A; Pangeni, Rajendra P et al. (2016) A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun 7:12885
Kim, Sung-Hak; Ezhilarasan, Ravesanker; Phillips, Emma et al. (2016) Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-?B-dependent Manner. Cancer Cell 29:201-13
Zhang, L; Zhang, W; Li, Y et al. (2016) SHP-2-upregulated ZEB1 is important for PDGFR?-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Oncogene 35:5641-5652
Zhang, Haipeng; Lin, Yuan; Li, Kai et al. (2016) Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections. Hum Gene Ther 27:700-11

Showing the most recent 10 out of 13 publications